Traditional Chinese Medicine as the Preventive and Therapeutic Remedy for COVID-19
- PMID: 36999715
- DOI: 10.2174/0929867330666230331084126
Traditional Chinese Medicine as the Preventive and Therapeutic Remedy for COVID-19
Abstract
The coronavirus disease 2019 (COVID-19) pandemic still has tremendous impacts on the global socio-economy and quality of living. The traditional Chinese Medicines (TCM) approach showed encouraging results during previous outbreaks of Severe Acute Respiratory Syndrome-related Coronavirus (SARS-CoV) and the Middle East Respiratory Syndrome Coronavirus (MERS-CoV). With limited treatment availability, TCM herbs and formulations could be useful to reduce COVID-19 symptoms and potential sources for discovering novel therapeutic targets. We reviewed 12 TCM herbs and formulations recommended for COVID-19 management by the National Health Commission and as National Administration of Traditional Chinese Medicine of the People's Republic of China. This article explored the Chinese national authorities' guidelines from 2003 to 2020, the scientific data in public databases for the recommended TCM remedies, and their potential mechanistic actions in COVID-19 management. Several TCM herbs and formulations could potentially benefit COVID-19 management. The recommended TCM oral preparations list includes Huoxiang zhengqi, Jinhua Qinggan, Lianhua Qingwen, and Shufeng jiedu; the recommended injection preparations comprise Xiyanping Xuebijing, Re-Du-Ning, Tanreqing, Xingnaojing, Shenfu, Shengmai, and Shenmai. TCM remedies are viable options for symptom alleviation and management of COVID-19. The current SARS-CoV-2 pandemic presents an opportunity to find novel therapeutic targets from TCM-active ingredients. Despite the recommendations in Chinese National guidelines, these remedies warrant further assessments in well-designed clinical trials to ascertain their efficacy in the treatment of COVID-19.
Keywords: COVID-19; Traditional Chinese medicine; coronavirus; herbal formulation; herbal remedy; natural compounds.; pneumonia.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
[Analysis on clinical study protocols of traditional Chinese medicine for coronavirus disease 2019].Zhongguo Zhong Yao Za Zhi. 2020 Mar;45(6):1232-1241. doi: 10.19540/j.cnki.cjcmm.20200220.501. Zhongguo Zhong Yao Za Zhi. 2020. PMID: 32281330 Chinese.
-
[Research progress of intervention of Chinese herbal medicine and its active components on human coronavirus].Zhongguo Zhong Yao Za Zhi. 2020 Mar;45(6):1263-1271. doi: 10.19540/j.cnki.cjcmm.20200219.501. Zhongguo Zhong Yao Za Zhi. 2020. PMID: 32281335 Review. Chinese.
-
Traditional Chinese medicine for treatment of novel infectious diseases: Current status and dilemma.Biosci Trends. 2021 Sep 22;15(4):201-204. doi: 10.5582/bst.2021.01263. Epub 2021 Jul 1. Biosci Trends. 2021. PMID: 34193750
-
Efficacy of Huoxiang Zhengqi dropping pills and Lianhua Qingwen granules in treatment of COVID-19: A randomized controlled trial.Pharmacol Res. 2020 Nov;161:105126. doi: 10.1016/j.phrs.2020.105126. Epub 2020 Aug 8. Pharmacol Res. 2020. PMID: 32781283 Free PMC article. Clinical Trial.
-
Traditional Chinese Medicine as a complementary therapy in combat with COVID-19-A review of evidence-based research and clinical practice.J Adv Nurs. 2021 Apr;77(4):1635-1644. doi: 10.1111/jan.14673. Epub 2020 Nov 29. J Adv Nurs. 2021. PMID: 33174654
Cited by
-
Exploring the pathogenesis of acute lung injury and its treatment through Traditional Chinese Medicine: a state-of-the-art review.Front Pharmacol. 2025 Jul 31;16:1592458. doi: 10.3389/fphar.2025.1592458. eCollection 2025. Front Pharmacol. 2025. PMID: 40822495 Free PMC article. Review.
-
Effectiveness of seven oral traditional Chinese medicines against mild or moderate COVID-19: An updated systematic review and network meta-analysis.Heliyon. 2024 Jul 24;10(15):e35081. doi: 10.1016/j.heliyon.2024.e35081. eCollection 2024 Aug 15. Heliyon. 2024. PMID: 39170141 Free PMC article.
-
Ayurvedic and Chinese Herbs against Coronaviruses.Curr Pharm Des. 2024;30(21):1681-1698. doi: 10.2174/0113816128269864231112094917. Curr Pharm Des. 2024. PMID: 38685809 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous